A multicenter clinical evaluation of the Clot Signature Analyzer.

@article{Fricke2004AMC,
  title={A multicenter clinical evaluation of the Clot Signature Analyzer.},
  author={William A. Fricke and Peter A Kouides and C. Kessler and Alvin H Schmaier and Yelena Krijanovski and K. C. Jagadeesan and J. Heinrich Joist},
  journal={Journal of thrombosis and haemostasis : JTH},
  year={2004},
  volume={2 5},
  pages={
          763-8
        }
}
BACKGROUND The Clot Signature Analyzer (CSA) was designed to assess global hemostasis as a screening assay using non-anticoagulated whole blood. Three different measurements are produced by the instrument: platelet hemostasis time (PHT), clot time (CT), and collagen-induced thrombus formation (CITF). OBJECTIVES The purpose of the present study was to determine normal ranges for these measurements and assess the performance of the CSA in patients with well-characterized hemostatic disorders… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 27 REFERENCES

Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion

CattaneoM, A Lecchi, B Agati, R Lombardi, ZighettiML
  • Thromb Res
  • 1999